Asset Management One’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
CCM
BG
MC
Asset Management One's NKTR Position: Q4 2019 in Review
Asset Management One sold out of Nektar Therapeutics (NKTR) in Q4 2019, closing a stake of 6,171 shares — an estimated $1.69M sold.
Asset Management One first reported a position in NKTR in Q3 2014 and held it in 16 quarters. The position peaked at $15.8M in Q3 2018. 280 funds tracked by Wall St. Rank hold NKTR as of Q4 2019.
- Asset Management One reported no remaining Nektar Therapeutics position as of Q4 2019 after selling out during the quarter.
- Asset Management One sold 6,171 Nektar Therapeutics shares in Q4 2019, an estimated $1.69M.
- Asset Management One first reported a position in Nektar Therapeutics in Q3 2014 and held it in 16 quarters.
- Asset Management One's Nektar Therapeutics position peaked at $15.8M in Q3 2018.
- 280 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2019.
Based on Asset Management One's 13F filing for Q4 2019, filed 14 Feb 2020.